UNSPSC 51453007: Piperazine dihydrobromide

This classification denotes an antihelminthic agent with the molecular formula C4H10N2.2BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AD5RF7D2AU, chemically known as piperazine, hydrobromide (1:2), but more generally known as piperazine dihydrobromide, which bears US NIH Compound Identifier 3017157. European Medicines Agency schedules piperazine dihydrobromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03841MIG.

Most nations, for tariff purposes, schedule piperazine dihydrobromide under HS 29335990. SMILES: C1CNCCN1.BR.BR.

UNSPSC 51453007 Piperazine dihydrobromide, a Commodity code, shows limited recent state and local procurement activity aligned to its nominal chemical scope. The recent opportunities posted under this code involve pharmaceutical procurement but diverge significantly from piperazine dihydrobromide specifically. One completed award by the Illinois Department of Public Health through the MMCAP Infuse cooperative purchasing vehicle supplied Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets to Chartwell Rx LLC under an Invitation for Bid; a separate Seminole County, Florida procurement sought Naloxone and Safe Drug Deactivation Systems through competitive bidding. Neither solicitation names piperazine dihydrobromide as a purchased item, suggesting the code may be misapplied to these opportunities or that state and local demand for piperazine dihydrobromide specifically is not currently generating posted solicitations.

State and local health departments and county public health offices appear as the active issuing bodies when pharmaceutical items are procured under this coding. Geographic activity, based on recent postings, centers on Illinois and Florida. The Illinois award to Chartwell Rx LLC totaled $2,999,999.11 over the contract life including renewal options, with an initial 12-month term and two additional renewal years; Seminole County's naloxone and deactivation-systems procurement specified 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries, a two-year initial term and one-year renewal option, though the due date listed (July 26, 2023) is a historical error in the source record. Cooperative purchasing vehicles and standard IFB processes are the solicitation mechanisms. Absent clear current demand for piperazine dihydrobromide specifically, pursuit interest should be low unless your firm supplies the chemical as an input to finished pharmaceuticals that states and localities do actively buy.